GDNF family receptor alpha-1 isoform b preproprotein (117-130)

GDNF family receptor alpha-1 isoform b preproprotein (117-130) is a synthetic peptide fragment derived from the sequence of the GDNF family receptor alpha-1 (GFRα1), specifically corresponding to residues 117 through 130 of the isoform b preproprotein. As a peptide compound, it represents a defined region of the GFRα1 protein, which is known to mediate signaling initiated by glial cell line-derived neurotrophic factor (GDNF) and related ligands. The precise sequence and defined length of this fragment make it a valuable tool for probing protein-protein interactions, receptor mapping, and functional studies within neurobiology and cell signaling research. Its biochemical relevance is rooted in its potential to mimic, compete with, or disrupt native GFRα1 interactions, offering researchers a targeted approach to dissecting the molecular mechanisms underlying GDNF-mediated pathways.

Receptor-ligand binding studies: As a well-characterized peptide fragment, this sequence is highly suitable for in vitro assays designed to investigate the binding interfaces between GFRα1 and its ligands, such as GDNF or neurturin. Researchers can use the peptide to map the minimal binding domains required for receptor interaction, elucidate the structural determinants of ligand recognition, or design competitive binding experiments. Such studies are crucial for advancing the understanding of neurotrophic signaling and for identifying potential modulators of receptor function.

Antibody epitope mapping: The defined amino acid sequence of residues 117-130 provides an ideal antigenic determinant for generating or validating antibodies specific to this region of GFRα1. By employing the peptide in immunoassays, scientists can determine the specificity and binding affinity of monoclonal or polyclonal antibodies, facilitating the development of reliable detection reagents for GFRα1 isoform b. This application is particularly valuable for studies focused on receptor localization, quantification, or isoform discrimination in complex biological samples.

Peptide-protein interaction analysis: The fragment serves as a practical probe in studies aimed at identifying novel protein partners or interaction motifs involving the GFRα1 extracellular domain. Using techniques such as peptide pull-down assays or surface plasmon resonance, researchers can screen for proteins that recognize or bind to this specific region, thereby uncovering new aspects of receptor biology and potential regulatory mechanisms. These insights can inform broader investigations into neurotrophic factor signaling networks.

Cell signaling modulation: By introducing the synthetic peptide into cell-based systems, investigators can assess its capacity to modulate downstream signaling events mediated by endogenous GFRα1. Acting as a potential competitive inhibitor or decoy, the peptide may alter the recruitment of co-receptors, influence receptor clustering, or impact the activation of intracellular pathways. Such experimental approaches enable the dissection of functional domains within the receptor and support the identification of critical residues involved in signal transduction.

Peptide synthesis and analytical validation: The sequence of GDNF family receptor alpha-1 isoform b preproprotein (117-130) is also valuable as a reference standard in peptide synthesis optimization and analytical method development. Laboratories can use the peptide to calibrate chromatographic systems, validate mass spectrometry protocols, or benchmark synthetic strategies for producing related bioactive peptides. Its defined structure and relevance to neurotrophic receptor biology make it an important tool for both methodological and mechanistic research in the peptide sciences.

1. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

2. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

3. High fat diet and GLP-1 drugs induce pancreatic injury in mice

4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

5. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling